AdisInsight

Every day matters in drug development. AdisInsight helps you quickly understand what’s happening and why, so you can make smarter strategic decisions and act with complete confidence. We help you minimize the risk of missing out on development prospects, commercial opportunities or investment possibilities through easy access to the latest drug data intelligence.

You need data insights to deliver your organization’s objectives and overcome your biggest challenges. That data needs to be trustworthy, up to date, and accurate. How to access and use that data should be up to you. That’s why we give you flexibility and control. You can opt to get our rich, validated data plugged straight into your internal analytics platforms and systems, so you have the freedom to explore and interrogate the data to meet your specific needs. Or you can benefit from additional layers of analysis and insights provided by our team of experts, giving you the relevant stories behind the data. So, in an industry where every day matters, you can quickly understand what’s happening, why, and what you should do next.

Start exploring - visit and preview the free version of the database today at adisinsight.springer.com.

Why AdisInsight?

AdisInsight can help you stay informed about drugs in development, identify investment opportunities, gain competitive advantage and increase efficiency.

Get a global perspective of the most compelling current evidence driving drug development:

An Introduction to AdisInsight

Downloads

AdisInsight brochure
AdisInsight brochure
(PDF, 2.57 MB)
AdisInsight Patents brochure
AdisInsight Patents brochure
(PDF, 214.60 KB)
AdisInsight Safety brochure
AdisInsight Safety brochure
(PDF, 109.35 KB)

Stay informed

Never miss an AdisInsight update again. Our dedicated communications bring together the latest knowledge from Springer Nature and other community experts to provide valuable insights to those who work within a research environment. Great for librarians, research managers, and R&D professionals.